Leucine/Sildenafil

亮氨酸/西地那非

Report date: 2023/08/17 20:03:08

Base Information

Drug NameLeucine/Sildenafil
Drug Alias NameLeu SilNS-0300
ClassificationSmall molecules
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Sildenafil Citrate
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNusirt Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNusirt Biopharma
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A